Literature DB >> 27999341

Exploring the Role of Vitamin D. Comments on Fleury et al. Sun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic Dysfunction. Int. J. Environ. Res. Public Health 2016, 13, 999.

Barbara J Boucher1, William B Grant2, Harjit Pal Bhattoa3.   

Abstract

n/a.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27999341      PMCID: PMC5201397          DOI: 10.3390/ijerph13121256

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


The mechanistic data presented in this interesting review suggests that long-term exposure to safe levels of ultra-violet radiation (UVR) has protective effects against the development of obesity and cardiovascular dysfunction beyond those induced by the cutaneous synthesis of vitamin D3 through factors such as the induction of cutaneous NO secretion [1]. Evidence from studies achieving comparable vitamin D status (serum 25-hydroxyvitamin D (25OHD) concentrations) is quoted [2], where features of metabolic syndrome were better suppressed by the UVR doses used than by supplementation. However, higher vitamin D status has been shown to have similar beneficial effects, for example on serum lipids [3], even without weight loss, and on insulin resistance [4]. Since homeostatic mechanisms come into effect both in the skin, and systemically, as vitamin D provision increases [5], it would be helpful to the authors’ arguments if UVR treated mice did not show evidence of increased homeostatic mechanism activity in comparison with the supplemented animals, despite the comparable achieved 25OHD findings. For example, in comparing data from animals treated with UVR, can the authors tell us whether or not serum parathyroid hormone values achieved were lower, or whether the serum calcium or serum calcitriol contents were higher than they were in the supplemented group? The absence of differences in these bio-markers of vitamin D provision and activity after treatment with UVR or vitamin D supplementation, where comparable serum 25OHD concentrations were achieved, would strengthen the authors’ arguments considerably.
  4 in total

1.  Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.

Authors:  Hamid Lorvand Amiri; Shahram Agah; Seyedeh Neda Mousavi; Agha Fatemeh Hosseini; Farzad Shidfar
Journal:  Arch Iran Med       Date:  2016-09       Impact factor: 1.354

2.  Ultraviolet radiation suppresses obesity and symptoms of metabolic syndrome independently of vitamin D in mice fed a high-fat diet.

Authors:  Sian Geldenhuys; Prue H Hart; Raelene Endersby; Peter Jacoby; Martin Feelisch; Richard B Weller; Vance Matthews; Shelley Gorman
Journal:  Diabetes       Date:  2014-11       Impact factor: 9.461

3.  Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial.

Authors:  Pamela R von Hurst; Welma Stonehouse; Jane Coad
Journal:  Br J Nutr       Date:  2009-09-28       Impact factor: 3.718

Review 4.  Sun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic Dysfunction.

Authors:  Naomi Fleury; Sian Geldenhuys; Shelley Gorman
Journal:  Int J Environ Res Public Health       Date:  2016-10-11       Impact factor: 3.390

  4 in total
  2 in total

1.  Effect of Methylation of the Hydrophilic Domain of Tocopheryl Ammonium-Based Lipids on their Nucleic Acid Delivery Properties.

Authors:  Hithavani Rapaka; Shireesha Manturthi; Mallikarjun Gosangi; Brijesh Lohchania; Srujan Marepally; Srilakshmi V Patri
Journal:  ACS Omega       Date:  2022-04-29

2.  Response to the Boucher et al. Comments on Fleury et al. Sun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic Dysfunction. Int. J. Environ. Res. Public Health 2016, 13, 999.

Authors:  Naomi Fleury; Sian Geldenhuys; Shelley Gorman
Journal:  Int J Environ Res Public Health       Date:  2016-12-18       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.